SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs ahead of the Q3 report is drawing attention, with traders focused on BRIUMVIs sales growth and possible guidance updates. Buyout and short-squeeze theories are circulating but remain speculation; the upcoming subcutaneous BRIUMVI data is another anticipated catalyst, while some traders warn the rally may already reflect high expectations.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Berkshires disclosed accumulation of a large Lennar stake has fueled bargain-buying interest, but traders are debating it against Hunterbrooks short-report allegations about Lennars transactions with spinoff Millrose. The dispute adds to concerns over weak results and outlook, pressured affordability, and elevated mortgage rates.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is drawing attention after traders cited a Northland upgrade tied to its C3 Code agentic-AI platform, alongside heavy call activity and the stocks potential as a short-squeeze candidate. Bullish traders see a turnaround opportunity, while skeptics point to declining revenue and persistent losses as reasons for caution.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave shares are drawing attention amid a steep selloff across quantum-computing stocks, with traders questioning whether high valuations, limited near-term commercialization and competition from classical AI can support the sector ahead of Q3 results. Some see the pullback as a buying opportunity, while others expect more downside.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, led by Dupixent and Eylea HD, drove a sharp share-price jump and a fresh high. Traders largely welcomed the report, while debating whether the breakout can hold and pointing to heavy call-option activity.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

Discussion centers on REalloys speculative role in a North American rare-earth and magnet supply chain ahead of 2027 U.S. defense sourcing restrictions, including its Army-linked Tooele opportunity and Tanbreez offtake agreement. Bulls point to strategic demand and potential sector momentum, while skeptics cite limited company updates, execution risk and sharp volatility; the Tooele discussions are not presented as a finalized agreement.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAs quarterly results topped expectations and its forward outlook was strong, but shares are falling amid weakness in tech and semiconductor equipment stocks. Traders are debating whether the selloff reflects sector-wide risk-off and valuation pressure, or an overreaction to solid fundamentals; analyst price-target cuts have added to the discussion.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

BLZE is under pressure after a steep pullback, with traders pointing to broader tech weakness and CoreWeaves decline while positioning around the upcoming earnings report. The community is split between dip-buyers betting on strong results or new contracts and cautious traders concerned that earnings could bring further losses.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is falling amid a broad semiconductor selloff that traders attribute largely to Intels weak forward guidance, with some also pointing to bearish put-option activity. The community is split between buying the pullback and expecting further downside, while noting the drop appears tied more to sector pressure than a clear Qualcomm-specific catalyst.

BitGo Holdings, Inc. operates as a digital asset infrastructure company delivering custody, wallets, staking, trading, financing, stablecoins, and settlement services from regulated cold storage. It focuses on accelerating the transition of the financial system to a digital asset economy. The company was founded by Michael Belshe and Ben Davenport in 2013 and is headquartered in Sioux Falls, SD.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGos latest earnings are drawing attention: traders are weighing strong revenue growth against a wider net loss, with some blaming the results for renewed share-price weakness. Bullish investors argue that Bitcoins recovery and expanding custody and institutional services could support a rebound, while others remain concerned about profitability and the stocks persistent decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WEN Stock Surges 15% As Trian Fund Offers $1.4B To Take The Burger Chain Private

Equity

Trian, along with Flynn Group, BlueFive Capital and Sixth Street Partners, have offered $7.35 per share in cash, a 19.7% premium to the stock’s closing price on Tuesday


Why Coca-Cola ETFs Are Good Bets After Q3 Earnings Beat

Coca-Cola beats Q3 earnings estimates and raises its outlook for the third straight quarter. Explore ETFs offering exposure to the beverage giant.

Will PepsiCo's Q3 Turnaround Boost These ETFs?

PEP's Q3'26 earnings beat estimates, putting PEP-heavy ETFs in focus as investors weigh revenue growth against margin pressures and cost-cutting plans.

STZ Stock Ticks Higher Premarket: Constellation Brands Trades At Cheapest Valuation In Over A Decade Ahead Of Q2 Earnings 

Investors will focus on Constellation’s beer sales, profit margins, and full-year outlook in Tuesday’s earnings report. 

Coca-Cola's Momentum Builds After Strong Q2 Earnings: ETFs to Consider

Coca-Cola beat Q2 expectations, raised its guidance and got an extra lift from World Cup demand. Here are some ETFs that offer meaningful exposure.

Bet on Fourth of July Celebrations With These ETFs

July 4 travel is set to stay strong despite inflation and high gas prices. These ETFs could benefit from holiday spending trends.

CPB Stock Slips Premarket After Earnings – But Retail Still Sees Campbell’s As A 'Defensive Play' 

Bank of America slashed its price target on CPB from $20 to $18.


Constellation Brands Soars on Upbeat Q4 Earnings: ETFs in Focus 

Constellation Brands beats Q4 estimates; shares jump 8.5%. Beer stays strong, but weak demand drags sales. ETFs with STZ exposure come into focus.

FARM Stock Sinks To 48-Year Lows – What Triggered The Collapse?

The company announced an agreement to be acquired by Royal Cup Coffee & Tea in an all-cash deal valued at $1.29 per share.

Follow Berkshire Hathaway With These ETF Areas

Berkshire Hathaway's latest 13F reveals Buffett's sector bets and portfolio shifts. Here's how investors can mirror the strategy using ETFs.

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Food & Beverage ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Trian and its affiliated investors already own about 31 million shares, or roughly 16.25% of the company.</li><li>Trian said Wendy’s needs significant investment to revive its business while managing upcoming debt repayments.</li><li>Trian had announced plans of acquiring Wendy’s in 2022 but scrapped the idea the following year.</li></ul>Shares of Wendy’s (WEN) shot up 15% on Wednesday after billionaire investor Nelson Peltz’s Trian Fund Management and its partners proposed acquiring the fast-food chain for about $1.4 billion.According to an SEC <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/30697/000093041326003164/xslSCHEDULE_13D_X02/primary_doc.xml">filing</a>, Trian, along with restaurant operator Flynn Group and investment firms BlueFive Capital and Sixth Street Partners, have offered $7.35 per share in cash, representing a 19.7% premium to the stock’s closing price of $6.14 on Tuesday.Trian and its affiliated investors already own about 31 million shares, or roughly 16.25% of the company. The proposed transaction would involve acquiring the remaining publicly held shares and taking Wendy’s private.<h2 class="st-heading-2">Why Trian Is Interested In Taking Wendy’s Private</h2>Trian said Wendy’s needs significant investment to revive its business while managing upcoming debt repayments. The parties stated that they believe private ownership is the better path and would provide the “long-duration capital needed to restore the business and the franchise system to a position of strength.”Wendy’s has struggled with declining customer traffic and increasing competition. On a call with analysts in August, CFO Steve Cirulis noted that U.S. same-store sales fell 7% in the second quarter (Q2), driven by a 12.5% decrease in traffic.<a class="mention" data-mention="$WEN" data-symbol-id="WEN" href="https://stocktwits.com/symbol/WEN" target="_blank">WEN shares</a> have declined nearly 25% so far in 2026 and more than 70% over the past five years.This is Trian’s second attempt at acquiring Wendy’s. In 2022, it informed Wendy’s board that it was exploring a potential transaction, though it did not submit a formal offer. However, Trian scrapped the idea the following year.&nbsp;<h2 class="st-heading-2">Retail Sees Scope For A Higher Offer</h2>Retail sentiment surrounding WEN on Stocktwits remained ‘bullish’ over the past 24 hours, amid ‘high’ message volumes. One user believes it’s a low offer, but said it’s a starting point.<img src="https://news.stocktwits-cdn.com/WEN_0ab7d49339.png" alt="WEN.png"><stembedurl>https://stocktwits.com/agriculture2000/message/667518882</stembedurl>Another user opined Wendy’s should reject any offer below $10 per share.<stembedurl>https://stocktwits.com/JohnAF/message/667522204</stembedurl>WEN was also among the top trending stocks on the platform at the time of writing.Also read:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lly-nvo-retatrutide-beats-ozempic-in-head-to-head-trial/cZU9h53R9GR">LLY Vs NVO: Lilly’s Retatrutide Beats Novo’s Ozempic In Head-To-Head Trial — Retatrutide More Than Doubles Weight Loss</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Wendy’s outlet in Bloomsburg, Pennsylvania, United States. 

Trian, along with Flynn Group, BlueFive Capital and Sixth Street Partners, have offered $7.35 per share in cash, a 19.7% premium to the stock’s closing price on Tuesday.

First Trust Exchange-Traded Fund III - First Trust Nasdaq Food & Beverage ETF

Invesco Dynamic Food & Beverage ETF

Wendy's Co

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

FTXG News